https://pharminent.com/82113-2/ 2026-06-18T20:35:15Z Pharminent en 2026-06-18T20:35:12Z Blog https://pharminent.com/82110-2/ 2026-06-18T20:04:45Z Pharminent en 2026-06-18T20:04:42Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-18-2026/ 2026-06-18T18:49:17Z Pharminent en Strategic News Watch • June 18, 2026 2026-06-18T18:49:15Z Blog https://pharminent.com/heart-drug-biotech-kardigan-raises-400m-in-upscaled-ipo/ 2026-06-18T15:14:55Z Pharminent en Heart drug biotech Kardigan raises $400m in upscaled IPO 2026-06-18T13:13:09Z Blog https://pharminent.com/biogen-pens-1bn-deal-to-buy-immunology-biotech-raythera/ 2026-06-18T15:15:06Z Pharminent en Biogen pens $1bn deal to buy immunology biotech RayThera 2026-06-18T08:58:53Z Blog https://pharminent.com/neuromarket-pulse/neuromarket-pulse-weekly-neuroscience-competitive-intelligence-june-17-2026/ 2026-06-17T22:09:14Z Pharminent en NeuroMarket Pulse • Weekly Neuroscience Competitive Intelligence • June 17, 2026 2026-06-17T22:09:11Z Blog https://pharminent.com/82051-2/ 2026-06-17T20:27:14Z Pharminent en 2026-06-17T20:27:11Z Blog https://pharminent.com/82048-2/ 2026-06-17T19:47:04Z Pharminent en 2026-06-17T19:47:01Z Blog https://pharminent.com/manufacturing-intelligence/manufacturing-intelligence-weekly-digest-june-17-2026/ 2026-06-17T18:49:00Z Pharminent en Manufacturing Intelligence • Weekly Digest • June 17, 2026 2026-06-17T18:48:58Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-17-2026/ 2026-06-17T16:08:09Z Pharminent en Strategic News Watch • June 17, 2026 2026-06-17T16:07:54Z Blog https://pharminent.com/uniqure-sets-course-to-us-filing-for-huntington-gene-therapy/ 2026-06-18T15:20:15Z Pharminent en uniQure sets course to US filing for Huntington gene therapy 2026-06-17T12:42:31Z Blog https://pharminent.com/jazz-orchestrates-a-4bn-cancer-alliance-with-abcellera/ 2026-06-17T20:16:30Z Pharminent en Jazz orchestrates a $4bn cancer alliance with AbCellera 2026-06-17T12:03:37Z Blog https://pharminent.com/edgewise-slides-as-cardiomyopathy-challenger-to-bms-cytokinetics-falls-short/ 2026-06-17T15:10:56Z Pharminent en Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short 2026-06-17T11:58:04Z Blog https://pharminent.com/merck-adds-to-biopharmas-ai-agenda-with-up-to-510m-protillion-pact/ 2026-06-17T15:06:19Z Pharminent en Merck adds to biopharma's AI agenda with up to $510M+ Protillion pact 2026-06-17T11:20:10Z Blog https://pharminent.com/moderna-builds-commercial-muscle-as-new-launches-loom/ 2026-06-17T15:09:08Z Pharminent en Moderna builds commercial muscle as new launches loom 2026-06-17T09:57:56Z Blog https://pharminent.com/altaris-to-acquire-simulations-plus-in-375m-all-cash-deal/ 2026-06-17T15:10:29Z Pharminent en Altaris to acquire Simulations Plus in $375m all-cash deal 2026-06-17T09:51:25Z Blog https://pharminent.com/eha26-bms-touts-positive-multiple-myeloma-data-for-two-pipeline-candidates/ 2026-06-17T20:15:57Z Pharminent en EHA26: BMS touts positive multiple myeloma data for two pipeline candidates 2026-06-17T09:32:42Z Blog https://pharminent.com/81994-2/ 2026-06-17T19:10:56Z Pharminent en 2026-06-16T20:41:14Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-june-16-2026/ 2026-06-16T20:29:19Z Pharminent en Oncology Intelligence Digest • June 16, 2026 2026-06-16T20:29:16Z Blog https://pharminent.com/oncology/oncology-intelligence-digest-june-12-2026/ 2026-06-16T20:16:22Z Pharminent en Oncology Intelligence Digest • June 12, 2026 2026-06-16T20:16:20Z Blog https://pharminent.com/81986-2/ 2026-06-16T18:02:12Z Pharminent en 2026-06-16T18:02:09Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-june-16-2026/ 2026-06-16T16:12:30Z Pharminent en Strategic News Watch • June 16, 2026 2026-06-16T16:12:27Z Blog https://pharminent.com/fda-moderna-appear-aligned-on-mrna-flu-shot-heading-into-adcomm/ 2026-06-16T15:24:53Z Pharminent en FDA, Moderna appear aligned on mRNA flu shot heading into adcomm 2026-06-16T15:24:53Z Blog https://pharminent.com/german-said-to-be-backtracking-on-pharma-rebate-changes/ 2026-06-16T16:23:56Z Pharminent en German said to be backtracking on pharma rebate changes 2026-06-16T12:44:11Z Blog https://pharminent.com/fda-and-mhra-forge-new-regulatory-collaboration-initiative/ 2026-06-16T15:43:20Z Pharminent en FDA and MHRA forge new regulatory collaboration initiative 2026-06-16T10:17:33Z Blog